Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Chimeric and humanized anti-human CTLA4 monoclonal antibodies and uses thereof

Chimeric and humanized anti-human CTLA4 monoclonal antibodies and uses thereof

US Patent 12473362 · Granted Nov 18, 2025

Assignee

No assignee recorded.

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Vascular flow-based microfluidic platform2025
Mithramycin oxime derivatives having increased selectivity and anti-cancer activ2025
Anti-CD79B protein monoclonal antibody, products containing the same, and uses t2025
CD80 and CD86 binding protein compositions and uses thereof2025
CD80 and CD86 binding protein compositions and uses thereof2025
CD80 and CD86 binding protein compositions and uses thereof2025
Anti-CD24 compositions and uses thereof2025
CD80 and CD86 binding protein compositions and uses thereof2025
Mutant anti-CTLA-4 antibodies with improved immunotherapeutic effect but attenua2024
Methods of use of CD24 for the prevention and treatment of leukemia relapse2024
Chimeric and humanized anti-human CTLA4 monoclonal antibodies and uses thereof2023
Methods of use of soluble CD24 for treating lupus nephritis2023